Mycophenolate Mofetil Powder, For Suspension
Product Images NDC 66689-307

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 66689-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vistapharm, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Mycophenolate 1)

Chemical structure diagram of Mycophenolate Mofetil, showing its molecular framework and functional groups as depicted in the image.*

FDA Label Image

Figure (Mycophenolate 2)

An instructional diagram showing components of an oral medication bottle assembly for Mycophenolate Mofetil powder for suspension. It depicts a child-resistant bottle cap, a bottle adapter, and the bottle itself, each labeled clearly with arrows indicating their position in the assembly.*

FDA Label Image

Fig 1 (Mycophenolate 3)

An illustration diagram of a syringe labeled with its main parts: plunger at the top, barrel in the middle with volume markings, and tip at the bottom. The image visually identifies these components without additional text or branding.*

FDA Label Image

Fig 1 (Mycophenolate 4)

Syringe-style dispenser labeled "Mycophenolate Mofetil for Oral Suspension" intended for oral use only. The device is plain with black printed text, featuring measurement markings and a flanged top for gripping, used to administer the 200 mg/mL powdered suspension formulation by VistaPharm, LLC.*

FDA Label Image

Fig 2 (Mycophenolate 5)

An instructional illustration showing a person holding a bottle of powder medication for suspension in one hand and a syringe in the other hand, demonstrating the process of withdrawing the reconstituted oral suspension.*

FDA Label Image

Bottle (Mycophenolate 6)

Label for Mycophenolate Mofetil for Oral Suspension, USP 200 mg/mL by VistaPharm, LLC. The label includes storage instructions, preparation directions, dosage information, phenylketonurics warning, pharmacist instructions, and contact details. The net content after constitution is 175 mL containing 35 grams of mycophenolate mofetil. The label emphasizes shaking the bottle well before use and discarding unused suspension 60 days after constitution.*

FDA Label Image

Carton (Mycophenolate 7)

Packaging label for Mycophenolate Mofetil 200 mg/mL powder for oral suspension, USP by VistaPharm, LLC. The label includes dosage strength, directions for reconstitution and use, pharmacist instructions, storage conditions, and manufacturer contact information for this prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.